Zili Hu

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center · ORCID：0000-0002-1987-730X

发表论文 49 篇 · 总被引 530 次 · h-index 14

代表论文

• Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis (2023 · Journal of Gastroenterology · 被引 63)
• YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment (2024 · Molecular Cancer · 被引 31)
• Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma (2025 · Radiology · 被引 22)
• Size‐Tunable Nanoregulator‐Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma (2023 · Advanced Healthcare Materials · 被引 22)
• Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma (2023 · International Immunopharmacology · 被引 17)
• Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion (2024 · Journal of Hepatocellular Carcinoma · 被引 16)